Insights

Framycetin antibiotic ear drops caused severe bilateral cochlear and vestibular damage. Framycetin was detected in inner ear fluid three weeks post-instillation, indicating prolonged toxicity.

Area of Science:

  • Ototoxicity
  • Pharmacology
  • Neuroscience

Background:

  • Framycetin is an aminoglycoside antibiotic used for topical ear infections.
  • Local administration of Framycetin is generally considered safe with minimal systemic absorption.
  • Previous literature reports rare instances of Framycetin toxicity.

Observation:

  • A case of total bilateral cochlear and vestibular destruction is presented.
  • The damage occurred after Framycetin instillation into the middle ear under pressure via a transtympanic drain.
  • This method of administration may increase the risk of ototoxicity.

Findings:

  • Framycetin was detected in perilymphatic fluid via stapes footplate puncture.
  • Detection occurred three weeks after the initial Framycetin instillation.
  • This confirms the persistence of the drug in the inner ear.

Implications:

  • Local Framycetin use, especially under pressure, can lead to severe, irreversible inner ear damage.
  • The findings highlight the potential for delayed and prolonged ototoxicity.
  • Clinical vigilance and careful administration techniques are crucial when using Framycetin in the middle ear.

Related Concept Videos

Hearing01:31

Hearing

When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
The Cochlea01:13

The Cochlea

The cochlea is a coiled structure in the inner ear that contains hair cells—the sensory receptors of the auditory system. Sound waves are transmitted to the cochlea by small bones attached to the eardrum called the ossicles, which vibrate the oval window that leads to the inner ear. This causes fluid in the chambers of the cochlea to move, vibrating the basilar membrane.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...